Australia approves Gilead’s remdesivir for COVID-19 treatment

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19), in California

SYDNEY: Australia has granted provisional approval to Gilead’s remdesivir as the first treatment option for COVID-19 in the country, the Therapeutic Goods Administration (TGA) said on Friday (Jul 10).

The approval is for adults and adolescent patients with severe COVID-19 symptoms and have been hospitalised, the Australian regulator said.

Remdesivir has become the treatment of choice for many countries against severely ill COVID-19 patients after the intravenously-administered medicine helped shorten hospital recovery times in a clinical trial.

The Australian approval broadens the use of remdesivir around the world – the United States has cleared it for emergency use and the European Commission has conditionally approved the treatment.

It is also approved as a COVID-19 therapy in Japan, Taiwan, India, Singapore and the United Arab Emirates.

Australia has been struggling to contain a COVID-19 outbreak in the country’s second most populous city and on Friday said it would halve the number of citizens allowed to return home from overseas each week.

Z24 News

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

AliExpress Russia eyes US$10 billion turnover by 2022-2023, up an estimated 66%

Fri Jul 10 , 2020
MOSCOW: AliExpress Russia, an e-commerce venture between Chinese online shopping giant Alibaba and Russian partners, said it was aiming for annual turnover of US$10 billion by 2022-2023, up from what analysts estimate is about US$6 billion now. Chief Executive Dmitry Sergeev, who did not give details on current turnover, told […]

Share

Social menu is not set. You need to create menu and assign it to Social Menu on Menu Settings.